According to the report titled ‘Global Anti-biofilm Wound Dressing Market Size study, by Mode of mechanism (Physical, Chemical, Biological and others), by Application (Chronic Wounds, Acute Wounds), and Regional Forecasts 2021-2027’, available with MarketStudyReport, global anti-biofilm wound dressing market was evaluated at USD 606.57 million in 2020 and is expected to grow at a healthy pace of 9% is projected to reach USD 1108.83 million during the forecast period 2021-2027.
 

Surging number of ambulatory surgical facilities and increasing prevalence of chronic diseases are driving the global anti-biofilm wound dressing market growth. As per the report by International Diabetes Federation, the condition of diabetes is predicted to climb from 366 million patients in 2013 to 552 million patients by 2030 globally.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4219735/
 

For the record, anti-biofilm is a natural polymer made from plants, prevalently derived from seaweed agar, and is used to treat infected diabetic wounds and chronic wound patients.
 

Despite the positive outlook, escalating treatment costs, and preference for advanced wound care products may stifle the market expansion.
 

Based on mode of mechanism, global anti-biofilm wound dressing industry is divided into biological, chemical, physical, and others. Speaking of application terrain, the bifurcation includes acute wounds, and chronic wounds. The report provides insights pertaining to the industry share held by each segment, their growth rate, and revenue contribution over 2021-2027.
 

Considering geographical scope, North America, Asia Pacific, Europe, and Latin America are the key contributors to market valuation. Because of rising frequency of laceration in sports, increasing number of road mishaps, and presence of numerous significant players, North America is the leading region in terms of market share currently.
 

Meanwhile, Asia Pacific market is likely to have a considerable growth rate over the projection period 2021-2027, owing to flourishing medical tourism sector in the region.
 

Speaking of the competitive landscape, top-tier players in global anti-biofilm wound dressing market are B. Braun Melsungen AG, ConvaTec Group plc, Coloplast A/S, Next Science Ltd., Molnlycke Health Care AB, Urgo Medical, BioMonde GmbH, 3M Company, Monarch Labs, and Smith & Nephew plc among others.